e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Diagnosis of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The utility of delta neutrophil index in differentiation of pulmonary tuberculosis from community acquired pneumonia
B. Jhun (Seoul, Republic of Korea), J. Lim (Seoul, Republic of Korea), H. Gil (Seoul, Republic of Korea), Y. Sim (Seoul, Republic of Korea), T. Shin (Seoul, Republic of Korea), D. Kim (Seoul, Republic of Korea)
Source:
International Congress 2018 – Diagnosis of tuberculosis
Session:
Diagnosis of tuberculosis
Session type:
Thematic Poster
Number:
4759
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Jhun (Seoul, Republic of Korea), J. Lim (Seoul, Republic of Korea), H. Gil (Seoul, Republic of Korea), Y. Sim (Seoul, Republic of Korea), T. Shin (Seoul, Republic of Korea), D. Kim (Seoul, Republic of Korea). The utility of delta neutrophil index in differentiation of pulmonary tuberculosis from community acquired pneumonia. 4759
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Lymphocyte-to-segmentonuclear neutrophil ratio in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Is Neutrophil-lymphocyte ratio useful for differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006
Evaluation of platelet count and indices in pulmonary tuberculosis and pneumonia
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011
Contribution of clinical pulmonary infection score in the diagnosis of hospital acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP)
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005
Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007
γ-interferon index - an indicator of therapeutic efficiency in pulmonary tuberculosis in children
Source: Eur Respir J 2005; 26: Suppl. 49, 644s
Year: 2005
Pulmonary function following treatment for pulmonary tuberculosis
Source: Annual Congress 2006 - Epidemiology and control of tuberculosis
Year: 2006
Defining stability in pneumonia and the non-responding pneumonia
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005
A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019
Over diagnosis of smear negative pulmonary tuberculosis in patients with allergic bronchopulmonary aspergillosis: A study from high tuberculosis burden country
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Pulmonary infections in HIV-infected patients: an update in the 21st century
Source: Eur Respir J 2012; 39: 730-745
Year: 2012
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019
Year: 2019
Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018
The absolute values of extravascular lung water content as a criterion in the evaluation of the functional operability of patients with progressive pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Pulmonary tuberculosis in the differential diagnosis of community-acquired pneumonia
Source: Eur Respir J 2012; 40: 279
Year: 2012
Pulmonary apoptosis and related markers in ventilator acquired pneumonia (VAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 13s
Year: 2003
Polymorphism of neutrophil granulocytes in children with latent tuberculosis infection and recurrent bronchitis
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept